Enalare Therapeutics
20 yrs experience in corporate finance and investment analysis. Currently co-Chief Investment Officer for public equity investing, with a focus on small cap growth companies. Prior experience in financial positions in the pharmaceutical industry. MBA Lehigh University, BAA Wharton, University of Pennsylvania.
This person is not in the org chart
This person is not in any offices
Enalare Therapeutics
Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from life-threatening acute respiratory and critical care conditions, including respiratory depression caused by drug overdose, post-surgery, and other conditions. The Company is planning to initiate pivotal studies for its lead compound ENA-001 in the near term.